Shandong Yanggu Huatai Chemical Co Ltd

Yanggu Huatai disclosed its 2026 semi-annual report on August 29. In the first half of the year, it achieved total operating revenue of 1.872 billion yuan, up 8.67% year-on-year, but net profit attributable to the parent company was 59.6986 million yuan, down 53.03% year-on-year. Non-GAAP net profit was 76.194 million yuan, down 38.65% year-on-year, and net cash flow from operating activities was 126 million yuan, down 32.73% year-on-year. The company's basic earnings per share were 0.13 yuan, and the weighted average return on equity was 1.65%. As of the close on August 28, the company's price-to-earnings ratio was about 33.75 times, and its price-to-book ratio was about 1.21 times. The company is mainly engaged in the production, research and development, and sales of rubber additives.

Hongbai New Materials, the world's top supplier of sulfur-containing silanes by market share, is enduring a harsh operating winter. It posted a net loss attributable to shareholders of 146 million yuan in 2025, followed by a further loss of 28.02 million yuan in the first quarter of 2026. Yet its share price briefly touched 14.9 yuan at the end of June, a three-year high, giving it a total market value of 8 billion yuan and a trailing price-to-earnings ratio of negative 47 times, a sharp deviation from the chemical raw materials sector average of around 25.2 times. The company's gross margin has slid from 33.89 percent in 2022 to just 2.21 percent in the first quarter of 2026. Its core silane coupling agent business has seen revenue shrink under the weight of an industry price war, while total costs rose 1.47 percent year on year. Depreciation, labour, and financial expenses stemming from capacity expansion have become rigid outlays. At the industry level, China's functional silane market is plagued by low-end overcapacity. Peers such as Chenguang New Materials, Yanggu Huatai, Sanfu Shares, and Jianghan New Materials continue to expand production, while downstream tyre demand growth is slowing. The resulting supply-demand imbalance has eroded pricing power. The high-end electronic-grade silane project that the company is pinning its hopes on has yet to break ground, and its Thailand production base faces multiple pressures, making it difficult to offset losses in the traditional business in the near term. During the period of losses, the actual controller's concert parties, financial investors, and senior executives have been selling down their holdings intensively. Controlling shareholder Hongbai Chemical reduced its stake by 19.5 million shares, and Xinyu Baolong has announced a clearance-style divestment plan. The concentrated cashing out by insiders is fuelling market concerns that the industry's downcycle will be prolonged.